<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AD628B56-8DB8-4820-A581-837A7DB98F41"><gtr:id>AD628B56-8DB8-4820-A581-837A7DB98F41</gtr:id><gtr:name>ReproGen Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E94047FA-2B64-4B5E-BF12-B480D820DA31"><gtr:id>E94047FA-2B64-4B5E-BF12-B480D820DA31</gtr:id><gtr:name>Beijing Genomics Institute (BGI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/43A3907A-12D0-4764-A70C-912239D9BFC6"><gtr:id>43A3907A-12D0-4764-A70C-912239D9BFC6</gtr:id><gtr:name>Nanjing Medical University</gtr:name><gtr:address><gtr:line1>101 Longmian Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AD628B56-8DB8-4820-A581-837A7DB98F41"><gtr:id>AD628B56-8DB8-4820-A581-837A7DB98F41</gtr:id><gtr:name>ReproGen Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E94047FA-2B64-4B5E-BF12-B480D820DA31"><gtr:id>E94047FA-2B64-4B5E-BF12-B480D820DA31</gtr:id><gtr:name>Beijing Genomics Institute (BGI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/43A3907A-12D0-4764-A70C-912239D9BFC6"><gtr:id>43A3907A-12D0-4764-A70C-912239D9BFC6</gtr:id><gtr:name>Nanjing Medical University</gtr:name><gtr:address><gtr:line1>101 Longmian Road</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/318B2157-DBD8-4366-BCF0-90E3FB15A75B"><gtr:id>318B2157-DBD8-4366-BCF0-90E3FB15A75B</gtr:id><gtr:firstName>Zhengming</gtr:firstName><gtr:surname>Chen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13049"><gtr:id>E644286F-2562-4276-818C-E7AD445632ED</gtr:id><gtr:title>High Throughput Science - Genomic and metabolmic analysis of haemorrhagic in the China Kadoorie Biobank</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_13049</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Stroke is the second leading cause of death globally, with much less known about its genetic and non-genetic determinants than for other major diseases such as ischaemic heart disease (IHD). In the UK, although intracerebral haemorrhage (ICH) accounts for only 10-15% of stroke cases, it causes more than half of all stroke deaths, and much severe disability. In China, about 30% of incident cases of stroke are due to ICH and almost all suspected cases of stroke will have CT/MRI after admission to hospital, allowing reliable determination of stroke subtypes. Better understanding of genetic and non-genetic risk factors for stroke subtypes is essential for improved prediction and prevention, and the development of new therapies. 
Twin studies and other family studies indicate a substantial genetic component to stroke risk, but there are to date no reports of well-powered GWAS studies of ICH. We will investigate the genetic contribution to ICH in a case-control study nested within the prospective China Kadoorie Biobank (CKB) study of 0.5 million people, which included extensive data by questionnaires and physical measurements and long-term storage of blood samples. In the CKB follow-up through linkage to death and disease registries and to the nationwide health insurance system on all hospitalised events has accumulated &amp;gt;20,000 first strokes. The GWAS will include 5,000 scan-confirmed incident cases of ICH and 10,000 controls, frequency-matched by area, age, sex, time of enrollment, etc. We will use a 800,000 SNP Affymetrix Axiom&amp;reg; myDesign&amp;reg; array, custom-designed to maximise whole-genome coverage in the Chinese population, enabling imputation of 6-10M SNPs and indels using relevant publically available reference panels. The 10,000 control subjects will also form a set of ?common controls? for genotyping studies of other diseases (e.g. ischaemic stroke, IHD).
Genome-wide significant associations will be validated by direct genotyping, and up to 100 variants identified as putatively associated with stroke risk (e.g. P&amp;lt;10 6) will be prioritised for replication in additional incident cases from CKB and other cohorts from China and East Asia, together with in silico replication in imputed GWAS data from available ethnically diverse cohorts.
In future, we plan to supplement the genetic analysis of these 15,000 subjects with metabolomic measurements on blood plasma based on mass spectrometry and proton nuclear magnetic resonance spectroscopy, and standard blood biomarker assays. Using system biology approaches to combine these ?-omics? data with detailed environmental and lifestyle information, we aim ultimately to understand the molecular basis of haemorrhagic stroke.</gtr:technicalSummary><gtr:fund><gtr:end>2016-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-09-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1484600</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Health Sciences</gtr:department><gtr:description>Newton Fund_University of Leicester</gtr:description><gtr:id>0A9AEF50-805A-4427-9916-6BF844F9BD45</gtr:id><gtr:impact>Nature genetic papers (in Press) &amp;quot;Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets&amp;quot;</gtr:impact><gtr:outcomeId>56dffdfe1b2c02.48300017-1</gtr:outcomeId><gtr:partnerContribution>Ongoing long-term collaboration.</gtr:partnerContribution><gtr:piContribution>CKB has included additional custom respiratory content into its array design and Prof Tobin will assist in examining this GWAs data alongside baseline and prospective datasets</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Beijing Genomics Institute</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Beijing Genomics Institute</gtr:description><gtr:id>31B8EFCB-2776-4E15-AFCB-926D7DD168B0</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56dffb10bf1df9.97315042-1</gtr:outcomeId><gtr:partnerContribution>BGI are providing the facilities and technical infrastructure for the conduct of genomic assays.</gtr:partnerContribution><gtr:piContribution>CKB are working with BGI on various research projects including DNA extravtion and large-scale GWAS of 100,000 CKB samples. We are also collaboratiing with BGI's Research organisation on a Mitochondrial DNA Project. This Project will involve sequencing the mitochondrial genomes of up to 300 samples (up to 100 parent-offspring trios) from the China Kadoorie Biobank. These results can be used to assess the inheritance patterns of mitochondrial genomes, including the extent of heteroplasmy and paternal inheritance. Framework agreement for the above project and future research collaborations ( eg on Whole genome sequencing, methylation) currently being finalised.)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>Wellcome Trust Centre for Human Genetics</gtr:description><gtr:id>3D33495E-26B7-4407-9972-52443C35D67B</gtr:id><gtr:impact>n/a</gtr:impact><gtr:outcomeId>56dffd041b2195.12299298-1</gtr:outcomeId><gtr:partnerContribution>Groups at the WTCHG will work closely with the CKB team in genome wide data imputation and analysis, for the current work on stroke, as well as future genomic projects, including the partial cohort-wide genotyping funded by the MRC-Newton fund.</gtr:partnerContribution><gtr:piContribution>Collaborated in the design of a customised genotyping array for genomewide analysis, which is complementary to the UK Biobank array, and will facilitate future joint projects in the genomics of common diseases.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Oxford - OCDEM</gtr:description><gtr:id>36181706-E93E-43E3-BE78-3FAC4CF48F19</gtr:id><gtr:impact>Already contributed several novel and interesting findings including piblished research papers</gtr:impact><gtr:outcomeId>58c7cea0733ca0.91540798-1</gtr:outcomeId><gtr:partnerContribution>Provision of a post graduate research assistant working on the the identification and characterization of genetic variants that influence predisposition to type 2 diabetes and related traits.</gtr:partnerContribution><gtr:piContribution>Access to relevant CKB data including genomics data and diabetes outcome data. Paper drafting and internal genomics expertise and supervision.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Stroke Genetics Consortium</gtr:department><gtr:description>International Stroke Genetics Consortium</gtr:description><gtr:id>DF0166B1-AAC3-4445-AD85-D182C7EC045D</gtr:id><gtr:impact>In Progress</gtr:impact><gtr:outcomeId>58c6d6b6303b69.83677453-1</gtr:outcomeId><gtr:partnerContribution>Long-term collaboration. Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta-analyses being conducted by this group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>The Genetic Investigation of ANthropometric Traits (GIANT)</gtr:department><gtr:description>GIANT: Genetic Investigation of ANthropometric Traits</gtr:description><gtr:id>3F412345-FC1F-45FC-8D0F-6E88EE248F98</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>58c6d3e2f0be65.90337679-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>ReproGen Consortium</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>ROHgen - (Runs of Homozygosity)</gtr:description><gtr:id>0450294F-9D32-41ED-B9BA-42218F96B07F</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>58c6d4eba444c4.68468440-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nanjing Medical University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Nanjing Medical University</gtr:description><gtr:id>2E96DBD3-6769-4942-9D94-3E8E99A92B52</gtr:id><gtr:impact>Papers currentry being drafted.</gtr:impact><gtr:outcomeId>56dffd57be0a30.13772555-1</gtr:outcomeId><gtr:partnerContribution>Contributing research and analystical expertise. CKB/ Oxford currently hosting a post-doctoral researcher from Nanjing who is working on this project.</gtr:partnerContribution><gtr:piContribution>Joint academic collaboration investigating stroke genetics among a case-control study of CKB participants.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Lipids Genetic Consortium (GLGC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Global Lipids Genetics Consortium</gtr:description><gtr:id>ADDD375A-F369-46FC-8D21-4F0950D5E619</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>58c6d724eee370.72859825-1</gtr:outcomeId><gtr:partnerContribution>Access to additional GWAS data to increase the likelihood of novel significant findings.</gtr:partnerContribution><gtr:piContribution>CKB plans to share genomics data or contribute to GWAS meta analyses being conducted by this group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>WuxiApp Tec, Shanghai, China</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94C0B3B0-6628-486D-A666-934414346F9B</gtr:id><gtr:impact>WuxiApp Tec, Shanghai, China</gtr:impact><gtr:outcomeId>56defdd3159576.62692745</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coverage on study in Pharmaceutical industry trade journal</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3400BA2E-1BB1-4D8F-AE5E-37D86DA690EA</gtr:id><gtr:impact>Some coverage of paper on LPa2 emphasising the implications for drug target discovery and pharmaceutical inductrial practice. 

https://www.drugtargetreview.com/news/12376/prospective-biobank-studies/</gtr:impact><gtr:outcomeId>58c6d10895d4c5.01386027</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:url>http://www.drugtargetreview.com/news/12376/prospective-biobank-studies/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5FE00ED0-AB93-427A-A92F-DC6B8BFB6020</gtr:id><gtr:title>Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58be80794ad452.56991453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C51DE7-19B7-4CF2-933D-703DE9E91BC7</gtr:id><gtr:title>Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults.</gtr:title><gtr:parentPublicationTitle>JAMA cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ec5d8d64b82eca349c6356a4f70572"><gtr:id>c9ec5d8d64b82eca349c6356a4f70572</gtr:id><gtr:otherNames>Millwood IY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a82b758447816.71182338</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13049</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>